VEON
VEON
VEON (VEON) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Cantor Fitzgerald | Initiated Coverage | Overweight | $112.00 | Oct 2, 2026 |
| Northland Capital Markets | Maintained | Outperform | $85.00 from $70.00 | Sep 29, 2026 |
| Northland Capital Markets | Initiated Coverage | Outperform | $70.00 | Jun 9, 2026 |
| Rothschild & Co | Initiated Coverage | Buy | $74.00 | Apr 16, 2026 |
| Benchmark | Maintained | Buy | $60.00 | Jun 16, 2025 |
| Benchmark | Maintained | Buy | $60.00 from $56.00 | Mar 25, 2025 |
| Benchmark | Maintained | Buy | $56.00 from $48.00 | Mar 3, 2025 |
| Benchmark | Initiated Coverage | Buy | $48.00 | Nov 12, 2024 |
Frequently asked questions
What is the latest analyst rating on VEON?
On Oct 2, 2026, Cantor Fitzgerald initiated coverage of VEON at Overweight with a price target of $112.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.